MENU
+Compare
AUTL
Stock ticker: NASDAQ
AS OF
Oct 17, 04:59 PM (EDT)
Price
$1.61
Change
-$0.06 (-3.57%)
Capitalization
431.15M

AUTL Autolus Therapeutics plc Forecast, Technical & Fundamental Analysis

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AUTL with price predictions
Oct 16, 2025

AUTL saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for AUTL moved out of overbought territory on October 13, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 50 similar instances where the indicator exited the overbought zone. In of the 50 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for AUTL moved below the 200-day moving average on September 19, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AUTL broke above its upper Bollinger Band on September 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AUTL's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 15, 2025. You may want to consider a long position or call options on AUTL as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AUTL moved above its 50-day moving average on October 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AUTL crossed bullishly above the 50-day moving average on October 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AUTL advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where AUTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.244) is normal, around the industry mean (24.427). P/E Ratio (0.000) is within average values for comparable stocks, (54.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.179). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (14.104) is also within normal values, averaging (351.995).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AUTL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AUTL is expected to report earnings to rise 20.61% to -21 cents per share on October 30

Autolus Therapeutics plc AUTL Stock Earnings Reports
Q3'25
Est.
$-0.22
Q2'25
Beat
by $0.05
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.10
The last earnings report on August 12 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 1.92M shares outstanding, the current market capitalization sits at 431.15M.
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVFX58.25-0.14
-0.24%
Touchstone Dynamic Large Cap Growth A
SILLX29.02-0.14
-0.48%
Franklin Global Equity C
TEGYX45.63-0.41
-0.89%
Touchstone Mid Cap Growth Y
PCAQX90.04-0.85
-0.94%
Principal Capital Appreciation R5
RYSVX216.17-3.04
-1.39%
Rydex S&P SmallCap 600 Pure Value A

AUTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-2.33%
OCUL - AUTL
47%
Loosely correlated
+2.22%
IPSC - AUTL
46%
Loosely correlated
-2.25%
CRSP - AUTL
44%
Loosely correlated
-4.72%
NTLA - AUTL
44%
Loosely correlated
-3.93%
ABEO - AUTL
43%
Loosely correlated
-1.08%
More